Maduka Odogwu, MD
Obstetrics & Gynecology · Mesquite, TXNPI 1861685372
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Intuitive Surgical at 53.0% of the total. Reporting peaked in 2024 at $4,412 and has fallen 82.1% since, to $791 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $49.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- AbbVie$762
- Mayne Pharma Commercial LLC$429
- Organon$323
- Minerva Surgical, Inc$158
- Pfizer$150
- plus $2K from 27 others
Across 7 payments — averaging $3789.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Duchesnay USA Incorporated$27K
What the payments were for
- Consulting fees$200%
- Travel & lodging$96013%
- Food & beverage$3,49547%
- Education$3,00040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $3,960 |
| AbbVie(2 entities) | 42 | $762 |
| Mayne Pharma Commercial LLC | 10 | $429 |
| Organon | 15 | $323 |
| Minerva Surgical, Inc | 3 | $158 |
| Pfizer | 7 | $150 |
| Coloplast | 1 | $141 |
| Shield Therapeutics Inc | 4 | $128 |
| Astellas Pharma US Inc | 1 | $124 |
| Bayer | 5 | $122 |
| Medtronic | 3 | $117 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $116 |
| Exeltis, USA Inc. | 7 | $116 |
| Femselect Inc. | 1 | $97 |
| Dexcom, Inc. | 5 | $88 |
| Mylan Pharmaceuticals Inc. | 4 | $82 |
| Aspira Women's Health Inc | 4 | $76 |
| Mission Pharmacal Company | 5 | $67 |
| Hologic Sales And Service, LLC | 3 | $64 |
| Merck | 4 | $52 |
| Biotissue Holdings Inc. | 1 | $41 |
| Baxter Healthcare | 2 | $37 |
| Evofem Biosciences, Inc. | 2 | $36 |
| Avion Pharmaceuticals | 2 | $34 |
| Coopersurgical, Inc. | 2 | $28 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $15 |
| Davol Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- Da Vinci Surgical System$916
- ALTIS$141
- Orilissa$125
- Veozah$124
- NEXTSTELLIS$122
- CAPLYTA$116
- ANNOVERA$109
How this compares
$7,476 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 44 | $201 |
| Fluconazole | 24 | $138 |
| Norethindrone | 11 | $108 |
| Ibuprofen | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mesquite
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.